The 2009 Fall Clinical Dermatology Conference convened October 15-18 in Las Vegas where psoriasis experts, such as Mark Lebwohl, M.D. and Alice Gottlieb, M.D. provided clinical updates on psoriasis management, including the use of topical medications (corticosteroids, Vectical) and biologics, such as the TNF Inhibitors (Amevive, Enbrel, Humira, Remicade) and a new biologic, Stelara, that blocks IL-12 and IL-23 that are associated with inflammation the the overgrowth of skin cells.
Some of the key points discussed included the importance for dermatologists to inquire about symptoms of psoriatic arthritis. Given the risk that long-term disability that may be caused by psoriatic arthritis, it is critical that any psoriasis therapy for a patient with arthritic symptoms, also help to minimize joint damage.
Showing posts with label biologics. Show all posts
Showing posts with label biologics. Show all posts
Sunday, October 18, 2009
Monday, July 6, 2009
"Psoriasis Doctors" Provides Psoriasis Information from Skin Care Experts
"Psoriasis Doctors", launched July 1, 2009, provides dermatologist-authored health education content to help people with psoriasis to understand their treatment option and manage their skin condition.
The Psoriasis Doctors Website is part of the "From Your Doctor"service from Vivacare Inc. that highlights Dermatologists who have authored particularly useful content regarding psoriasis management. For instance, Helen Torok, M.D. with Trillium Creek Dermatology of Medina, Ohio, published information about phototherapy services offered by her practice that appears on Psoriasis Doctors.
The content covers a wide range of psoriasis topics, including psoriasis basics, psoriasis types, psoriasis severity, topical medications (clobetasol, Vectical), phototherapy (PUVA, UVB), and new "biologics" (Amevive, Enbrel, Humira, Remicade, and Stelara).
Subscribe to:
Posts (Atom)
